Manufacturing roundup: GenBioPro looks to counter Mississippi trigger law; Pisgah Labs to invest $55M in NC expansion
As the issues from the Roe V. Wade decision continue to cascade in various circles, including the biotech world, one manufacturer is looking to push back against state law.
According to a report from Bloomberg BNN, mifepristone manufacturer GenBioPro is looking to challenge a Mississippi anti-abortion law set into motion by the US Supreme Court’s reversal of Roe v. Wade, stating that the move is keeping its product off the shelves.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.